Sign In

Login

Password

Forgot Password ? Sign Up

Testosterone buciclate (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Testosterone buciclate" in English language version.

refsWebsite
Global rank English rank
8books.google.com
3rd place
3rd place
4doi.org
2nd place
2nd place
4nih.gov
4th place
4th place
1psu.edu
207th place
136th place
1semanticscholar.org
11th place
8th place

books.google.com

  • Nieschlag E, Behre HM, Engelmann U, Schwarzer U (29 June 2013). "Male Contrabution to Contraception". In Nieschlag E, Behre H (eds.). Andrology: Male Reproductive Health and Dysfunction. Springer Science & Business Media. pp. 316, 412. ISBN 978-3-662-04491-9.
  • Hargreave TB (15 August 1997). "Towards male hormonal contraception". In Coutifaris C, Mastroianni L (eds.). New Horizons in Reproductive Medicine. CRC Press. pp. 100–. ISBN 978-1-85070-793-6.
  • William Llewellyn (2009). Anabolics. Molecular Nutrition Llc. pp. 138–140. ISBN 978-0967930473.
  • Behre HM (13 February 1996). "Testosterone Buciclate". In Bhasin S (ed.). Pharmacology, Biology, and Clinical Applications of Androgens: Current Status and Future Prospects. John Wiley & Sons. pp. 472–. ISBN 978-0-471-13320-9.
  • Behre HM, Weinbauer GF, Nieschlag E (13 February 1996). "Testosterone Buciclate". In Bhasin S, Gabelnick HL, Spieler JM (eds.). Pharmacology, Biology, and Clinical Applications of Androgens: Current Status and Future Prospects. John Wiley & Sons. pp. 471–480. ISBN 978-0-471-13320-9. Testosterone buciclate is applied intramuscularly as a microcrystalline aqueous suspension. [...] After air milling [...] of crystalline testosterone buciclate to a particle size of at least 75% in the range of 10 - 50 μm, the drug was [...] suspended in sterile, aqueous suspension vehicle [...].
  • Luetjens CM, Wistuba J, Weinbauer G, Nieschlag E (28 October 2007). "The Leydig Cell as a Target for Male Contraception". In Payne AH, Hardy MP (eds.). The Leydig Cell in Health and Disease. Springer Science & Business Media. pp. 423–. ISBN 978-1-59745-453-7.
  • Nieschlag E, Behre HM (13 January 2010). "Testosterone Therapy". In Nieschlag E, Behre HM, Nieschlag S (eds.). Andrology: Male Reproductive Health and Dysfunction. Springer Science & Business Media. pp. 441–446. ISBN 978-3-540-78355-8.
  • Wang C, Swerdloff RS (27 May 2003). "Androgen Pharmacology and Delivery Systems". In Bagatell C, Bremner WJ (eds.). Androgens in Health and Disease. Springer Science & Business Media. pp. 146–. ISBN 978-1-59259-388-0.

doi.org

  • Behre HM, Abshagen K, Oettel M, Hübler D, Nieschlag E (May 1999). "Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies". European Journal of Endocrinology. 140 (5): 414–419. CiteSeerX 10.1.1.503.1752. doi:10.1530/eje.0.1400414. PMID 10229906. S2CID 22597244.
  • Behre HM, Nieschlag E (November 1992). "Testosterone buciclate (20 Aet-1) in hypogonadal men: pharmacokinetics and pharmacodynamics of the new long-acting androgen ester". The Journal of Clinical Endocrinology and Metabolism. 75 (5): 1204–1210. doi:10.1210/jcem.75.5.1430080. PMID 1430080.
  • Behre HM, Baus S, Kliesch S, Keck C, Simoni M, Nieschlag E (August 1995). "Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders". The Journal of Clinical Endocrinology and Metabolism. 80 (8): 2394–2403. doi:10.1210/jcem.80.8.7543113. PMID 7543113.
  • Nieschlag E, Kumar N, Sitruk-Ware R (March 2013). "7α-methyl-19-nortestosterone (MENTR): the population council's contribution to research on male contraception and treatment of hypogonadism". Contraception. 87 (3): 288–295. doi:10.1016/j.contraception.2012.08.036. PMID 23063338.

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Behre HM, Abshagen K, Oettel M, Hübler D, Nieschlag E (May 1999). "Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies". European Journal of Endocrinology. 140 (5): 414–419. CiteSeerX 10.1.1.503.1752. doi:10.1530/eje.0.1400414. PMID 10229906. S2CID 22597244.
  • Behre HM, Nieschlag E (November 1992). "Testosterone buciclate (20 Aet-1) in hypogonadal men: pharmacokinetics and pharmacodynamics of the new long-acting androgen ester". The Journal of Clinical Endocrinology and Metabolism. 75 (5): 1204–1210. doi:10.1210/jcem.75.5.1430080. PMID 1430080.
  • Behre HM, Baus S, Kliesch S, Keck C, Simoni M, Nieschlag E (August 1995). "Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders". The Journal of Clinical Endocrinology and Metabolism. 80 (8): 2394–2403. doi:10.1210/jcem.80.8.7543113. PMID 7543113.
  • Nieschlag E, Kumar N, Sitruk-Ware R (March 2013). "7α-methyl-19-nortestosterone (MENTR): the population council's contribution to research on male contraception and treatment of hypogonadism". Contraception. 87 (3): 288–295. doi:10.1016/j.contraception.2012.08.036. PMID 23063338.

psu.edu

citeseerx.ist.psu.edu

semanticscholar.org

api.semanticscholar.org